What the analyst said

Scotiabank analyst Pat Colville lowered the price target on Oracle (NYSE: ORCL) to $205 (from $215) while maintaining a Sector Outperform rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ORCL trades at $145. The 22 analysts who set a target in the last 3 months range from $155 to $400, with a median of $233. This $205 target is 12% below the median.

12-month window: day 0 of 365, closes on October 29, 2027.

Track record

This callOpen: a 12-month target, scored on October 29, 2027, a year after the note.

Firm track recordToo early to score Scotiabank: price targets are 12-month calls and fewer than 5 of its targets are a year old. 3 of its 6 open targets have already been reached. How we score

Scotiabank on Oracle

Scotiabank price targets on Oracle

2 calls from June 11, 2026 to October 29, 2026. The target went from $241 to $205 (−15%). The rating stayed Buy.

Scotiabank targetORCL share price
  1. October 29, 2026 This noteTarget cut from $241 (−15%)Buy$205
  2. June 11, 2026Earliest call shownBuy$241
Share

Other analysts on Oracle

GuggenheimBuy Kept rating and price target Oct 29 $400maintained OppenheimerBuy Kept rating and price target Oct 29 $275maintained BairdBuy Kept rating and price target Oct 29 $215maintained Melius ResearchBuy Kept rating and price target Oct 29 $170maintained Citizens JMPBuy Kept rating and price target Oct 29 $285maintained
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.